Privia Health Group Inc reports results for the quarter ended in January - Earnings Summary

Privia Health

09/05/2024 14:31

* Privia Health Group Inc  PRVA.OQ  reported quarterly
adjusted
earnings of 2 cents​​ per share for the quarter ended in
January, lower than the same quarter last year, when the company
reported EPS of 6 cents.  The mean expectation of
twenty analysts for the quarter was for earnings of 5 cents per
share. Wall Street expected results to range from 3 cents to 7
cents per share.
    * Revenue fell 37% to $415.24 million from a year ago;
analysts
expected $680.00 million. 
    * Privia Health Group Inc's reported EPS for the quarter was
2
cents​.
    * The company reported quarterly net income of $2.98
million.
    * Privia Health Group Inc shares had fallen by 3.7% this
quarter and lost 18.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 16.4%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 18 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the healthcare
facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Privia Health
Group Inc is $26.50 
This summary was machine generated from LSEG data May 9 at 01:31
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.05           0.02           Missed
 Dec. 31 2023      0.04           0.02           Missed
 Sep. 30 2023      0.05           0.05           Met
 Jun. 30 2023      0.06           0.06           Met